BCP
AMGN icon

Blue Chip Partners’s Amgen AMGN Stock Holding History

Blue Chip Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.98M Sell
5,635
-361
-6% -$129K 0.14% 63
2025
Q4 		$1.96M Sell
5,996
-450
-7% -$143K 0.14% 65
2025
Q3 		$1.82M Sell
6,446
-88
-1% -$25.5K 0.14% 63
2025
Q2 		$1.82M Sell
6,534
-687
-10% -$195K 0.15% 61
2025
Q1 		$2.25M Sell
7,221
-797
-10% -$235K 0.19% 56
2024
Q4 		$2.09M Sell
8,018
-209
-3% -$62K 0.18% 63
2024
Q3 		$2.65M Sell
8,227
-425
-5% -$139K 0.23% 54
2024
Q2 		$2.7M Sell
8,652
-361
-4% -$106K 0.25% 49
2024
Q1 		$2.56M Sell
9,013
-1,116
-11% -$327K 0.25% 49
2023
Q4 		$2.92M Sell
10,129
-154
-1% -$42K 0.3% 47
2023
Q3 		$2.76M Sell
10,283
-930
-8% -$232K 0.33% 42
2023
Q2 		$2.49M Sell
11,213
-2,660
-19% -$617K 0.28% 52
2023
Q1 		$3.35M Sell
13,873
-3,010
-18% -$739K 0.4% 45
2022
Q4 		$4.43M Sell
16,883
-3,260
-16% -$874K 0.55% 44
2022
Q3 		$4.54M Buy
20,143
+71
+0.4% +$17.2K 0.62% 41
2022
Q2 		$4.88M Sell
20,072
-1,349
-6% -$331K 0.62% 41
2022
Q1 		$5.18M Sell
21,421
-4,962
-19% -$1.14M 0.64% 40
2021
Q4 		$5.93M Sell
26,383
-6,129
-19% -$1.29M 0.74% 34
2021
Q3 		$6.91M Sell
32,512
-28,668
-47% -$6.6M 0.97% 33
2021
Q2 		$14.9M Buy
61,180
+1,975
+3% +$486K 2.13% 22
2021
Q1 		$14.7M Buy
59,205
+1,369
+2% +$327K 2.26% 21
2020
Q4 		$13.3M Buy
57,836
+1,243
+2% +$287K 2.08% 27
2020
Q3 		$14.4M Buy
56,593
+1,294
+2% +$321K 2.56% 16
2020
Q2 		$13M Buy
55,299
+1,702
+3% +$388K 2.56% 14
2020
Q1 		$10.9M Sell
53,597
-3,077
-5% -$672K 2.7% 13
2019
Q4 		$13.7M Buy
56,674
+1,767
+3% +$390K 2.6% 8
2019
Q3 		$10.6M Buy
54,907
+3,214
+6% +$617K 2.25% 19
2019
Q2 		$9.53M Buy
51,693
+2,609
+5% +$467K 2.13% 19
2019
Q1 		$9.32M Buy
49,084
+2,830
+6% +$540K 2.21% 18
2018
Q4 		$9M Buy
46,254
+2,328
+5% +$454K 2.26% 9
2018
Q3 		$9.11M Buy
43,926
+4,105
+10% +$809K 2.22% 14
2018
Q2 		$7.35M Buy
39,821
+6,429
+19% +$1.14M 1.95% 19
2018
Q1 		$5.69M Buy
33,392
+4,247
+15% +$780K 1.58% 25
2017
Q4 		$5.07M Buy
29,145
+3,908
+15% +$692K 1.5% 25
2017
Q3 		$4.71M Buy
25,237
+1,086
+4% +$192K 1.52% 21
2017
Q2 		$4.16M Buy
24,151
+2,689
+13% +$437K 1.45% 23
2017
Q1 		$3.52M Buy
21,462
+1,652
+8% +$274K 1.33% 25
2016
Q4 		$2.9M Buy
19,810
+2,235
+13% +$336K 1.13% 31
2016
Q3 		$2.93M Buy
17,575
+1,435
+9% +$243K 1.3% 31
2016
Q2 		$2.46M Buy
16,140
+1,802
+13% +$280K 1.11% 33
2016
Q1 		$2.15M Buy
14,338
+1,399
+11% +$208K 1.05% 38
2015
Q4 		$2.1M Buy
12,939
+946
+8% +$149K 1.09% 33
2015
Q3 		$1.66M Buy
11,993
+895
+8% +$141K 1.06% 38
2015
Q2 		$1.7M Buy
11,098
+8,160
+278% +$1.31M 1.09% 36
2015
Q1 		$470K Buy
2,938
+142
+5% +$22.4K 0.32% 66
2014
Q4 		$445K Buy
+2,796
New +$436K 0.31% 66

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Blue Chip Partners's AMGN Position: Q1 2026 in Review

Blue Chip Partners reduced its Amgen (AMGN) stake by 6% in Q1 2026, selling an estimated $129K and leaving 5,635 shares worth $1.98M. The position accounts for 0.14% of the portfolio, ranked #63.

Blue Chip Partners first reported a position in AMGN in Q4 2014 and has held it in 46 quarters since. The position peaked at $14.9M in Q2 2021. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Blue Chip Partners held 5,635 shares of Amgen worth $1.98M as of Q1 2026.
  • Blue Chip Partners sold 361 Amgen shares in Q1 2026, an estimated $129K.
  • Amgen made up 0.14% of Blue Chip Partners's portfolio in Q1 2026, its #63 holding.
  • Blue Chip Partners first reported a position in Amgen in Q4 2014 and has held it in 46 quarters since.
  • Blue Chip Partners's Amgen position peaked at $14.9M in Q2 2021.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Blue Chip Partners's 13F filing for Q1 2026, filed 15 May 2026.